Pharmaceutical Processing - FDA approves NEXIUM for the Treatment of Zollinger-Ellison Syndrome.(Industry News)
AstraZeneca has announced that the FDA has approved a new indication for the prescription proton pump inhibitor NEXIUM[R] (esomeprazole magnesium) for the treatment of Zollinger-Ellison Syndrome (ZES). NEXIUM already is indicated for the treatment of gastroesophageal reflux disease (GERD) in adults and children ages 12 to 17, and to reduce the risk of NSAID-associated gastric ulcers in at-risk patients.
Most Popular
10 Jobs That Pay $30 An Hour
Public Speaking: 7 Secrets Of Great Public Speakers
3 Questions No Job Seeker Ever Wants To Be Asked?
13 Job Interview Mistakes To Avoid
Job Interviewing: How To Sell Yourself Like A Product
ZES is a rare but serious chronic condition characterized by the development of tumors that secrete excessive levels of gastrin, a hormone that stimulates acid production by . neurontin. ..
Read the rest of this article with a Free Trial at HighBeam Research.